Skip to main content
Rashmi K. Murthy, MD, Oncology, Houston, TX

Rashmi K. Murthy MD MBE

Breast Cancer


Associate Professor, Department of Breast Medical Oncology

Join to View Full Profile
  • 1155 Pressler StreetHouston, TX 77030

Dr. Murthy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
  • Baylor College of Medicine
    Baylor College of MedicineResidency, Internal Medicine, 2008 - 2011
  • University of Alabama School of Medicine
    University of Alabama School of MedicineClass of 2008
  • University of Pennyslvania
    University of PennyslvaniaMBE, Bioethics, 2003 - 2004
  • University of Alabama-Birmingham
    University of Alabama-BirminghamBA, Philosophy, Magna Cum Laude, 2000 - 2003

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2023 - 2027
  • TX State Medical License
    TX State Medical License 2010 - 2026
  • WA State Medical License
    WA State Medical License 2023 - 2026
  • AL State Medical License
    AL State Medical License 2023 - 2025
  • AZ State Medical License
    AZ State Medical License 2023 - 2025
  • GA State Medical License
    GA State Medical License 2023 - 2025
  • LA State Medical License
    LA State Medical License 2023 - 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Clinical benefit of tucatinib after isolated brain progression: A retrospective pooled analysis of tucatinib phase 1b studies in HER2+ breast cancer. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: